Ketogenic Medical Food Shows Promise in Angelman Syndrome Trial
A recent clinical trial explored the safety and potential benefits of a ketogenic medical food formulation (KF) in children with Angelman syndrome. Despite the promising results, the company behind the formulation remains unidentified.
The trial, conducted in four phases over sixteen weeks, aimed to assess the tolerability of the high-ketone supplement. Thirteen children completed the study, accepting and tolerating the powder formulation. Two adverse events were reported, but overall, the supplement was deemed safe and well-tolerated.
The primary goal was met, with no indication of harm to the patients. Half of the families chose to continue using the formula post-study, suggesting potential benefits. While the supplement's efficacy could not be determined due to the small sample size, almost all participants experienced a softening in stool consistency, a positive effect.
The dietary supplement, designed to mimic the effects of a ketogenic diet, showed promise in this small trial. However, further research with larger participant groups is needed to confirm its efficacy and long-term effects.
The ketogenic medical food formulation showed promising results in a small clinical trial with children with Angelman syndrome. Despite the unknown developer, the supplement was well-tolerated and may have provided benefits. Larger-scale studies are needed to confirm these findings and determine the supplement's efficacy.
